These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4751654)

  • 1. [New, special preparations registered in Austria].
    Wien Klin Wochenschr; 1973 Nov; 85(46):762-5. PubMed ID: 4751654
    [No Abstract]   [Full Text] [Related]  

  • 2. [Benzbromarone in the treatment of hyperuricemias].
    Ravera R
    Minerva Med; 1975 Mar; 66(17):783-800. PubMed ID: 1093064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of LC 75 (Ampliuril pH) in the states of hyperuricemia].
    Warembourg H; Stalnikiewicz G
    Lille Med; 1975 Apr; 20(4):410-4. PubMed ID: 1080232
    [No Abstract]   [Full Text] [Related]  

  • 4. [Benzbromarone in the treatment of gout].
    Kawenoki-Minc E; Brzozowska-Jurkowska AM
    Reumatologia; 1980; 18(1):61-7. PubMed ID: 6994191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study].
    Barcelo P; Santamaria A
    Verh Dtsch Ges Rheumatol; 1969; 1():361-70. PubMed ID: 5403652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F
    Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new uricemia-lowering agent: benziodarone. Its use in therapy of urate retention in the course of chronic renal insufficiency].
    Bossini A; De Martino Rosaroll G
    Policlinico Prat; 1969 Jul; 76(30):961-73. PubMed ID: 5402682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and therapy of gout (uricopathy). Guide lines for daily practice].
    Matzkies F; Berg G
    Fortschr Med; 1972 Dec; 90(34):1268-70. PubMed ID: 4660491
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the hypouricemic effect of benziodarone in chronic renal insufficiency].
    Ponticelli C; Locatelli F; Graziani G
    Arch Ital Urol Nefrol; 1967; 40(6):461-75. PubMed ID: 5607121
    [No Abstract]   [Full Text] [Related]  

  • 12. A new potent hypouricemic drug. A clinical trial of the drug in a group of gouty patients.
    Serry MM
    J Egypt Med Assoc; 1979; 62(1-2):255-61. PubMed ID: 400475
    [No Abstract]   [Full Text] [Related]  

  • 13. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of benziodarone on hyperuricemia in gout].
    Cottet J; Vittu C
    Presse Med (1893); 1967 May; 75(26):1355-6. PubMed ID: 6026564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Benziodarone in the treatment of hyperuricemia].
    Ravera M
    Clin Ter; 1970 Mar; 52(5):407-16. PubMed ID: 5421984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Benzbromaron in the treatment of hyperuricemia].
    Charbonnet F; Rossier J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(44):1337-44. PubMed ID: 4795197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hyperuricemia with benziodarone].
    Ravault PP; Vignon G; Lejeune E; Bouvier M; Queneau P
    Presse Therm Clim; 1970; 107(2):74-9. PubMed ID: 5468122
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of amplivix in gout patients and nongouty arthrosic hyperuricemics].
    Doumerg C
    Rhumatologie; 1968 Oct; 20(8):285-8. PubMed ID: 5712175
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
    Mertz DP; Sulzberger I; Klöpfer M
    Munch Med Wochenschr; 1970 Feb; 112(6):241-7. PubMed ID: 5537894
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hypouricemic effect of benziodarone].
    Gospodinoff L; Salvini S
    Clin Ter; 1969 Oct; 51(2):153-8. PubMed ID: 5365825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.